| A day after authorizing the first antiviral pill to treat COVID-19, the FDA approves Merck's molnupiravir. The prescription medication is designed to stop the progression of COVID-19 from mild to severe symptoms in people at high risk. Though not as effective as Pfizer's pill, it is one more tool to help prevent illness from a COVID-19 infection. | | News Alert Thursday, December 23 | | | | | | | | | | | |
Belum ada tanggapan untuk "News alert: The FDA authorizes a second antiviral to fight COVID, a Merck pill that can be taken at home"
Posting Komentar